期刊文献+

3岁以下儿童丙泊酚药动学研究 被引量:3

Study on pharmacokinetics of propofol in children under three years old
暂未订购
导出
摘要 目的研究3岁以下儿童丙泊酚(异丙酚)药物动力学特征。方法选择3岁以下无心、肺、肝、肾和中枢神经疾病的手术儿童12例。单次静脉注射异丙酚3mg.kg-1。应用高效液相色谱法测定给药后不同时间点的血清中异丙酚浓度。用3P87实用药代动力学程序计算各项药动学参数。结果3岁以下儿童异丙酚诱导静脉麻醉主要药动学参数t1/2α=(2.372±0.565)m in,t1/2β=(16.364±4.442)m in,t1/2γ=(416.591±97.184)m in,Vd=(7.980±1.863)L.kg-1,CL=(0.015±0.007)L.kg-1.m in-1,AUC=(267.353±100.247)μg.m in.mL-1。结论3岁以下儿童异丙酚诱导静脉麻醉符合开放性三室模型特征,具有分布快、分布广等特点。 OBJECTIVE To study on the pharmacokinetics of propofol in children under three years old. METHODS To choose twelve surgery children under three years old and without heart,lung, liver, kidney and central nerve disease. A single dose of propofol 3mg · kg^-1 injection of veto was given. The plasma concentrations of propofol were measured by high performance liquid chin matograph. The plasma concentrations obtained from individual child were analyzed by 3P87 pharmacokinetics software. RESULTS The main pharmacokinetics parameters ( T1/2α, T1/2β, T1/2γ , Vd, C L, AUC ) in child under three years old were 2. 372 ± 0. 565min 16.364 ± 4. 442min,416.591 ± 97. 184rain,7. 980 ± 1. 863 L · kg^-1 ,0.015 ± 0.007 L · kg^-1 · min^-1, 267. 353 ± 100.247μg ·min ·mL^- i. CONCLUSION The phannacokinetics of propofol as iv induction anaesthesia in children under three years old was fitted three-compartment open model. Propofol was distributed quickly and widely in body.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2006年第2期132-133,共2页 Chinese Journal of Modern Applied Pharmacy
关键词 异丙酚 药动学 儿童 propofol pharmacokinetics children
  • 相关文献

参考文献5

  • 1VuyK J. TCI: Supplementation and drug interactions. Anaesthesia, 1998,153(sl ) :35.
  • 2王增寿,上官王宁,金胜威,连庆泉.高效液相色谱法测定儿童血清异丙酚浓度[J].儿科药学杂志,2003,9(1):4-6. 被引量:9
  • 3傅丽红,冉国侠,许伟彬,卡哈尔,逢全,焦士林,曹泽兵.异丙酚临床药物动力学研究[J].中国医院药学杂志,1997,17(2):51-53. 被引量:17
  • 4VuyK J, Mertens M J, Vletter AA, et al. Alfentanyl modifies the pharmacokinetecs of propofol in volunteers [ J ]. ASA Annual Meeting, 1997,87(3A) :A300.
  • 5Pavlin DJ, Coda B, Shen DD, et al. Effects of combining propofol and alfentanyl on ventilation, analgesia, Sedation and emesis in human Volunteers. Anesthesiology, 1996,84(1):23.

二级参考文献5

共引文献24

同被引文献21

  • 1张兴安,芮建中,吴群林,施冲,王若松.NONMEM法分析静滴异丙酚在中国人体的群体药代动力学[J].中国临床药理学杂志,2004,20(6):444-448. 被引量:34
  • 2宋丹丹,张铁铮,夏东亚,许霁虹,孙莹杰,刘晓江.硫喷妥钠在混合液中对异丙酚药代动力学的影响[J].沈阳部队医药,2005,18(4):249-250. 被引量:1
  • 3余松林.医学统计学[M].北京:人民卫生出版社,2003.19.
  • 4彭娅.贾振飞,程刚.丙泊酚及其制剂的研究进展[J].中国药剂学杂志,2012,10(1):17-25.
  • 5CORTINEZ L I, ANDERSON B J, PENNA A, et al. Influ- ence of obesity on propofol pharmacokinetics : derivation of a pharmacokinetic model [ J ]. British J Anae, 2010, 105 (4) :448-456.
  • 6MARTIN W, GAVIN N C, SCHRAAG K S. Use of target controlled infusion to derive age and gender covariates for propofol clearance [ J ]. Clin Pharmacokinet, 2008,47 ( 2 ) : 119-127.
  • 7HIRAOKA H, YAMAMOTO K, MIYOSHI S, et al. Kidneys contribute to the extrahepatic clearance of propofol in humans but not lungs and brain [ J ]. British J Clin Pharm, 2005,60(2) : 176-182.
  • 8MERTENS M J, OLOFSEN E, BURM A G, et al. Mixed- effects modeling of the influence of alfentanil on propofol pharmacokinetics[ J]. Anesthesiology,2004,100(4) :795.
  • 9SCHUTYLER J, IHMSEN H . Population pharmacokinetics of propofol [ J ]. Anesthesiology,2000,92 (6) :727-738.
  • 10LI Y H, RUI J Z, ZHOU Y G, et al. Population pharm- acokinetics of propofol in Chinese patients [ J ]. Acta Pharmacol Sin,2003,24(6) :581-588.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部